Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share insight into the company’s recent developments during an investor webinar on December 18, 2019 at 4:00 p.m. ET. A live Q&A session with Dr. Muchnicki will follow the presentation.
December 17, 2019
· 2 min read